Clinical Trial Update: Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up [Phase 1]

View source ↗

Summary

Long-term follow-up data from an early-phase gene therapy trial for Chronic Granulomatous Disease are reported. The document updates on safety and durability ou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• Gene therapy for Chronic Granulomatous Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Granulomatous Disease, Communicable Disease | Phase 1 | Status: COMPLETED